Sapir Venture Partners

Enzymit is a developer of a discovery platform focused on creating new-to-nature enzymes through advanced computational design and deep learning. The company employs high-throughput testing methods to innovate novel enzymes applicable across various sectors, including fine chemical manufacturing, food technology, health, and biodefense. By leveraging these technologies, Enzymit aims to help global manufacturers enhance production efficiency, reduce operational costs, and support sustainability initiatives in their processes.

DeepCure Inc. offers drugs discovery services using artificial intelligence technology. Its products include De-novo Lead Discovery, Artificial Intelligence-driven Lead Optimization, and MoIDB. De-novo Lead Discovery uses artificial intelligence algorithms to analyze drug candidates from virtual library. Artificial Intelligence-driven Lead Optimization identifies optimization steps to improve the development of drugs. MolDB is designed to maximize scale, diversity, and synthesizability of chemical search space. DeepCure Inc. develops new drug through molecular feature extraction, MoIDB, artificial intelligence predictive modeling and feedback loop. The company was founded in 2018 and is based in Boston, Massachusetts.

Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Developer of a meeting planner software designed to guide employees through the meeting agenda. The company's software works in concert with the existing infrastructure and helps in planning, real-time work allocation, and agenda tracking, enabling organizations to utilize less time in meetings and be more productive.

Fabric helps brands deliver social and immersive augmented reality experiences to customers in real-time.

Developing technology to fight mosquitoes with mosquitoes.

Suridata.ai is focused on enhancing organizations' ability to manage and secure sensitive data through its data discovery and protection platform. By utilizing advanced autonomous learning capabilities, the platform can be trained to identify various types of sensitive data across different sectors in a matter of days. This approach allows for rapid and accurate discovery and classification of data, distinguishing Suridata.ai from traditional solutions that rely on predefined rules and require extensive training. The visibility and control provided by the platform enable organizations to implement effective actions for data protection, deletion, and access management, ensuring compliance with privacy regulations while securing the use of SaaS applications.

Gabriel is building an advanced network of devices that help keep you safe in the face of threats like active shooter situations. In response to a dramatic rise in safety & security threats around the world, they created a cutting-edge alert and crisis management system that is easy to install, implement and affordable to all. Schools and public buildings are their first priority, where a mix of smart sensors and software send instant alerts, provide critical communication and management tools to survive or prepare for today's dangers. All at a fraction of the cost of existing solutions.

Strattic Ltd. is a company based in Jerusalem, Israel, that specializes in converting WordPress websites into static versions to enhance speed and security. Founded in 2016, Strattic's platform utilizes serverless architecture to make websites faster and more scalable while minimizing vulnerabilities. By disconnecting the dynamic aspects of a WordPress site from the web, Strattic allows site owners to continue managing their content and plugins in the familiar WordPress environment. Once changes are made, they can deploy their site with a single click, resulting in a static site composed of HTML, CSS, and JavaScript. This process makes the websites virtually unhackable and leverages a global network of content delivery networks (CDNs) to ensure quick and secure delivery.

Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

CaliberMind is a B2B Customer Data Platform that powers Revenue Marketers at mParticle, Fidelis Cybersecurity, Datavail and other mid-market enterprises, with the data, business intelligence, and automation they need to grow revenue faster, together with sales. The platform lets marketing and ops teams answer simple business questions and automate manual workflows with 1-click: Which marketing programs generate the most revenue? How is my marketing campaign performing? How fast are we driving revenue through the pipeline? How's our close rate trending over time? Unlike CRM reporting and expensive, general BI tools that take months to implement, run on bad/ partial data and require data analytics skills, CaliberMind can be implemented in one hour by marketing and ops managers. The platform has 10x faster time-to-insights at 10% of the cost of traditional IT/ BI solutions.

Lance Global, Inc. specializes in developing expense management and tax prediction software tailored for freelancers. Founded in 2017 and based in New York, the company’s platform centralizes essential financial tasks, allowing users to manage invoices, payments, and accounts efficiently. The software not only organizes expenses and maximizes tax deductions but also aids freelancers in registering their businesses. Recognizing the unique challenges faced by freelancers, Lance aims to provide a mobile-first, intuitive solution that streamlines financial management and supports the growth of its users.

GoodLight LP develops a platform that helps its users in risk analytics for potential issues with individuals. The services provided by the platform are, early signs of employee risk, assessing the dynamic risk profile of employees post-hiring, monitoring many data sources, and looking for abnormalities. The alerts generated by the platform will help organizations to manage their risk, reducing costs to deal with misconduct. The company was founded in 2010 and is headquartered in Calgary, Canada.

DeepCure Inc. offers drugs discovery services using artificial intelligence technology. Its products include De-novo Lead Discovery, Artificial Intelligence-driven Lead Optimization, and MoIDB. De-novo Lead Discovery uses artificial intelligence algorithms to analyze drug candidates from virtual library. Artificial Intelligence-driven Lead Optimization identifies optimization steps to improve the development of drugs. MolDB is designed to maximize scale, diversity, and synthesizability of chemical search space. DeepCure Inc. develops new drug through molecular feature extraction, MoIDB, artificial intelligence predictive modeling and feedback loop. The company was founded in 2018 and is based in Boston, Massachusetts.

SynVaccine develops preventive viral vaccines for various major human pathogens. It owns licenses for disruptive technologies that enable the computational rational design of viral genomes and physical DNA editing of viral vaccine genome libraries. Tuval Ben Yehezkel founded SynVaccine in 2013. It has its headquarters in Tel Aviv in Israel.

Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

ConsortiaTX, Inc. is a seed stage, pre-clinical bio-therapeutics company that emerged from research laboratories at Brigham & Women’s Hospital and Children’s Hospital in Boston. The company’s intellectual property around food allergies and the human gut microbiome is based on the work of Lynn Bry, M.D., Ph.D., Georg Gerber, M.D., Ph.D. (both at BWH), and Talal Chatilla, Ph.D. (at CHB) and others.

PlanetWatchers, Inc. is a San Francisco-based company that provides a geospatial analytics platform designed for monitoring natural assets across various sectors, including forestry and oil and gas. Founded in 2016, the company utilizes a software-as-a-service (SaaS) model to deliver its solutions to enterprises, governments, and non-governmental organizations. By integrating advanced machine learning algorithms, elastic cloud infrastructure, and multi-source satellite sensors, PlanetWatchers offers a comprehensive monitoring and alerting system. This technology enables users to manage large-scale assets effectively, providing critical information that supports decision-making and operational efficiency at both global and regional levels.